Teva Pharmaceutical Industries | TEVA - Selling And Administration Expenses

Stock Price
9,290.00
Daily Change
-84.00 -0.90%
Monthly
-11.78%
Yearly
56.48%
Q1 Forecast
9,016.87

Teva Pharmaceutical Industries reported $1.12B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.62B 252M Jun/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Guangzhou Baiy CNY 1.75B 290.62M Sep/2025
Jiangsu Hengrui CNY 3.23B 111.82M Sep/2025
Kalbe Farma IDR 2.51T 410.17B Sep/2025
Richter Gedeon HUF 52.3B 1.18B Sep/2025
Sh Fosun Pharma CNY 3.12B 22.02M Sep/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025